%X Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies, which occurs in 4–21% of women during reproductive age and is the most common form of hyperandrogenism [1, 2]. The clinical manifestations of PCOS are diverse, and most of them accompany a woman throughout her life, varying depending on age, ethnicity, constitutional and other factors. Due to the increase in average life expectancy, modern women spend quite a long period in peri- and postmenopause, which determines the need to monitor the clinical manifestations of PCOS, its long-term complications, as well as the features of the onset and course of age-associated diseases in this endocrinopathy [3–6].
%O Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/3390)
%J Journal of Universal Science Research
%L arxiv55853
%I "Research Science and Innovation house" LLC
%R oai:ojs.pkp.sfu.ca:article/3390
%D 2023
%A Nomurodova Shahnoza Gaffarovna
%A Hamidova Manzura Sattarovna
%A Imamov Elmurod Norkuchkarovich
%T POLYCYSTIC OVARIAN SYNDROME AND MENOPAUSE
%K syndrome, ovaries, menopause, postmenopause, endocrinopathies, polycystic disease, uterus.